CSF p-tau231: A biomarker for early preclinical Alzheimer?

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Suárez-Calvet, Marc
• dc.date.accessioned 2022-09-15T07:15:45Z
• dc.date.available 2022-09-15T07:15:45Z
• dc.date.issued 2022
• dc.format.mimetype application/pdf
• dc.identifier.citation Suárez-Calvet M. CSF p-tau231: A biomarker for early preclinical Alzheimer? EBioMedicine. 2022 Mar;77:103936. DOI: 10.1016/j.ebiom.2022.103936
• dc.identifier.doi http://dx.doi.org/10.1016/j.ebiom.2022.103936
• dc.identifier.issn 2352-3964
• dc.identifier.uri http://hdl.handle.net/10230/54075
• dc.language.iso eng
• dc.publisher Elsevier
• dc.relation.ispartof EBioMedicine. 2022 Mar;77:103936
• dc.rights © 2022 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/
• dc.title CSF p-tau231: A biomarker for early preclinical Alzheimer?
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion